Annals ofAutoimmunity

Volume: 3 - Number: 27 - September 15, 2004

Outstanding

The Joy of Citrulline: New Insights into the Diagnosis, Pathogenesis, and Treatment of Rheumatoid Arthritis

Mechanisms of Erosion in Rheumatoid Arthritis

Rheumatoid Arthritis: Is the Disease Becoming Milder or Is Treatment Improving?

Effective use of TNF antagonists

Closing remarks

Closing remarks

Editorial

The Joy of Citrulline: New Insights into the Diagnosis, Pathogenesis, and Treatment of Rheumatoid Arthritis

Antiphospholipid Antibody Syndrome: Further Evidence to Guide Clinical Practice?

Observational Cohort Studies and Well Controlled Clinical Trials — We Need Them Both!

Why I No Longer Accept Pens (or Other "Gifts") from Industry (and Why You Shouldn't Either)

Mechanisms of Erosion in Rheumatoid Arthritis

Using Vaccine Responses to Plumb the Immunologic Consequences of Tumor Necrosis Factor Blockade with Etanercept

Blind Insight: Eyeing Anti-Tumor Necrosis Factor Treatment in Uveitis Associated with Behçet's Disease

Studies of Attrition in Rheumatological Databases

Is There a Rationale for Switching from One Anti-TNF Agent to Another?

Rheumatoid Arthritis: Is the Disease Becoming Milder or Is Treatment Improving?

Measuring Patient Health Status in RA — What Is a Minimal Clinically Important Difference?

What I Would Like to Know About Leflunomide

Coping with Chronic Pain: What Can We Learn from Pain Self-Efficacy Beliefs?

Hypertension, NSAID, and Lessons Learned

Review

Current and new antitumor necrosis factor agents in perspective

Do anti-TNF agents have equal efficacy in patients with rheumatoid arthritis?

Does safety make a difference in selecting the right TNF antagonist?

Does route of administration affect the outcome of TNF antagonist therapy?

Effective use of TNF antagonists

Treating psoriatic arthritis: how effective are TNF antagonists?

Expanding the armamentarium for the spondyloarthropathies